All articles by Linda Stewart – Page 164
-
NewsScientists probe amoeba that thrives at 125°F
Biologists study the mechanisms that have allowed microbial eukaryotes to thrive in the extreme conditions of a geothermal lake.
-
NewsContagious omicron strain replicates early in infection
New research used engineered mice to compare SARS-COV-2 omicron subvariants and found one of them – BA.5 – was more virulent likely due to its ability to rapidly replicate early during infection.
-
NewsValneva announces new IXIARO® supply contract with the US government
Specialty vaccine company Valneva SE has announced the signing of a new $32 million contract with the United States Department of Defense for the supply of its Japanese encephalitis vaccine, IXIARO®.
-
NewsAntibiotics can help some bacteria survive for longer
Scientists have found a surprising effect of some antibiotics on certain bacteria – that the drugs can sometimes benefit bacteria, helping them live longer.
-
NewsResearchers pioneer safe chemotherapy methods for treating bacterial infections
Antibiotic resistant bacteria are a threat to human lives, and yet the development of new drugs to treat bacterial infections is slow. A group of proven drugs used in cancer treatment for decades could possibly be the solution. A new class of antibiotics is now being developed by researchers at ...
-
NewsNew vaccine technology could protect from future viruses and variants
Studies of a ‘future-proof’ vaccine candidate have shown that just one antigen can be modified to provide a broadly protective immune response in animals.
-
NewsAntiviral drug linked to SARS-CoV-2 mutations
Researchers have uncovered a link between an antiviral drug for COVID-19 infections called molnupiravir and a pattern of mutations in the SARS-CoV-2 virus.
-
NewsResearchers reveal how microbes return after a wildfire
A study suggests that dispersal - through air or rain, for example - plays a major role in microbial succession after a destructive fire.
-
NewsTeselaGen Biotechnology renews partnership with Joint BioEnergy Institute
TeselaGen Biotechnology has announced that it is extending its relationship with Joint BioEnergy Institute (JBEI) through 2027 via a new multi-year contract.
-
NewsNanoparticles made from plant viruses could be farmers’ new ally
Engineers have developed nanoparticles, fashioned from plant viruses, that can deliver pesticide molecules to soil depths that were previously unreachable.
-
NewsClimate warming could impact forest resilience by disrupting fungal networks
Researchers find that warming trends will likely result in major disturbances of networks of fungi, potentially harming forest resilience.
-
NewsAssays for rapid and visual detection of monkey B virus
Two recombinase polymerase amplification (RPA) assays have been developed for Monkey B virus that target two conserved genes combined with a one-off, closed visualization strip device
-
NewsNew research reveals gut microbiota link to colitis - and therapetic strategies
Researchers have revealed a new and critical role of Axin1 in regulating intestinal epithelial development and microbial homeostasis.
-
-
NewsNanoparticle vaccine candidate shows promise against emerging tick-borne virus
Researchers have used nanoparticles to develop a potential vaccine candidate against Dabie Bandavirus, formerly known as Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV), a tick-borne virus that has no prevention, treatment or cure.
-
NewsHops compound reduces abundance of gut microbe associated with metabolic syndrome
Researchers have shown in a mouse model and lab cultures that a compound derived from hops reduces the abundance of a gut bacterium associated with metabolic syndrome.
-
NewsDiscovery in mosquitoes could lead to new strategy against dengue fever
Researchers have discovered that a protein in the mosquito Aedes aegypti , Argonaute 2, has a key role - via several biological mechanisms - in keeping mosquitoes healthy and active despite the presence of viral infections like dengue and Zika.
-
NewsLumen Bioscience wins historic $1.5 million Wilkes Center Climate Prize
The Seattle-based biotech company has developed a natural solution to eliminate the microorganisms in the cow gut that produces methane gas, a major cause of global warming.
-
NewsCOVID-19 could hold key to spotting viruses with pandemic potential
Certain SARS-CoV-2 variants of concern are evolving to do a better job of shutting down human innate immune responses, according to new research.
-
CareersIgnoring the rise of anti-science could usher back once-deadly diseases
As a wave of anti-science sentiment sweeps the globe, scientists need to speak up, says paediatric vaccine scientist Dr Peter Hotez in an interview with The Microbiologist as he launches his new book.